Free Preview — Investor scores & financials for ROL. Sign up for full buy targets.
Start Free

Is Rollins, Inc. (ROL) Undervalued? Valuation & Fair Price

At $33.53, 3 of the 4 frameworks would pass on Rollins, Inc. today — Warren Buffett, Benjamin Graham, and Phil Town (Rule #1) rate it Avoid and Peter Lynch rates it Hold. Each model calculates its own fair value and margin of safety; create a free account to see the exact buy price behind every verdict.

RO

Rollins, Inc.

ROL

Consumer Cyclical · Specialty Business Services · NYSE

$33.53

P/E 33.2×

CEO

Jerry E. Gahlhoff Jr.

Sector

Consumer Cyclical

Industry

Specialty Business Services

Rollins, Inc. operates a network of subsidiaries that specialize in delivering pest and wildlife management solutions to a diverse clientele, encompassing both homeowners and commercial enterprises, throughout the United States and globally. For residential properties, the company offers comprehensive pest control, safeguarding homes from prevalent invaders such as rodents, insects, and other nuisance animals. Furthermore, it devises tailored pest management strategies for various business sectors, including healthcare, foodservice, and logistics. Beyond standard pest solutions, Rollins, Inc. also provides a range of termite defense options, from conventional treatments to baiting systems, alongside other complementary services. The firm serves its customers directly through its own operations as well as through its extensive franchisee network. Established in 1948, Rollins, Inc. maintains its headquarters in Atlanta, Georgia.

Investor scorecard

How the four investors rate Rollins, Inc.

3 of 4 frameworks urge caution

Warren Buffett
94%Avoid
Benjamin Graham
43%Avoid
Peter Lynch
78%Hold
Phil Town (Rule #1)
82%Avoid

Investor model analysis

Details locked

At $33.53, 3 of 4 frameworks say Avoid

Business Quality75/100

Intrinsic Value (DCF)

Warren Buffett's valuation model · select an investor above to switch

Intrinsic Value

Locked — upgrade to view

Buy Below

Locked — upgrade to view

Strong Buy

Locked — upgrade to view

Margin of Safety

Locked — upgrade to view

Unlock buy targets with a free account

Get started

Create a free account to see buy targets, full checklists & risk analysis Get started

Insider & congress activity

Are insiders buying ROL?

Over recent SEC Form 4 filings, ROL insiders bought $0 and sold $3.4B of stock across 27 open-market trades. Insiders sell for many reasons, but they buy for one.

Bought $0Sold $3.4B
Recent open-market insider trades for ROL
InsiderActionSharesValueDate
Chandler Elizabeth BCLO, GC, CORPORATE SECRETARYSell14,201$843KFeb 25, 2026
ROLLINS GARY WEXECUTIVE CHAIRMAN EMERITUSSell10,355$651KJan 28, 2026
Chandler Elizabeth BCLO, GC, CORPORATE SECRETARYSell1,329$84KJan 28, 2026
Tesh Thomas DChief Admin. OfficerSell323$20KJan 28, 2026
Gahlhoff Jerry Jr.PRESIDENT & CEOSell1,307$82KJan 28, 2026

Members of Congress have also reported 19 trades in ROL. See the full insider & congress timeline.

Source: SEC Form 4 filings. Open-market buys & sells only. Not investment advice.

See the interactive insider chart & every trade

Scenario analysis

Bear, base & bull

Three growth assumptions, three fair values — and where today's price lands

What's working

Key strengths

Identified by Buffett framework analysis

Return on Equity

ROE Consistency

ROE Quality (Low Leverage)

Risk factors & concerns — free account

Unlock

Company financials

5-Year Financials

Income statement highlights — annual, USD

Metric20252024202320222021
Revenue$3.8B
$3.4B
$3.1B
$2.7B
$2.4B
Rev. Growth+11.0%+10.3%+14.0%+11.2%
Net Income$527M$466M$435M$369M$357M
Net Margin14.0%13.8%14.2%13.7%14.7%
EPS (Diluted)$1.09$0.96$0.89$0.75$0.72
Free Cash FlowLocked — upgrade to viewLocked — upgrade to viewLocked — upgrade to viewLocked — upgrade to viewLocked — upgrade to view

Full analysis included

See the complete picture for ROL

Exact buy targets, margin of safety, detailed investor checklists, and risk breakdown — all frameworks, all numbers.

Buy & sell targetsFull checklistRisk breakdown

Free: 3 analyses/month · Pay per stock: $4.99 · Pro: $19.99/mo

More Consumer Cyclical stocks

Educational Use Only · Not Financial Advice

Analysis, scores, valuations, and buy zones are derived from publicly documented investor frameworks (Buffett, Lynch, Benjamin Graham, Phil Town) for learning purposes only. They are not recommendations from licensed financial advisors. Past performance does not guarantee future results. Prices may be delayed up to 15 minutes. Always conduct your own research before making any investment decisions.